Ligand Pharmaceuticals LGND Accrued Manufacturing Costs
Accrued Manufacturing Costs at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's accrued manufacturing costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's accrued manufacturing costs?
- Ligand Pharmaceuticals (LGND) reported accrued manufacturing costs of $3.55M in Q1 2026.
- How has Ligand Pharmaceuticals's accrued manufacturing costs changed year-over-year?
- Ligand Pharmaceuticals's accrued manufacturing costs increased by 87.9% year-over-year, from $1.89M to $3.55M.
- What is the long-term trend for Ligand Pharmaceuticals's accrued manufacturing costs?
- Over 5 years (2020 to 2025), Ligand Pharmaceuticals's accrued manufacturing costs has grown at a -6.2% compound annual growth rate (CAGR), from $8.81M to $6.39M.